Xtane 25 mg (Exemestane 25 mg)

Xtane 25 mg contains Exemestane, a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which helps slow or stop the growth of estrogen-dependent cancer cells.

This medication is often prescribed after initial treatment with tamoxifen, especially in patients who have completed 2–3 years of tamoxifen therapy. By switching to Xtane, the risk of cancer recurrence can be reduced more effectively in some cases.

Xtane is taken orally once daily, preferably after a meal to improve absorption. The full course of treatment depends on the patient’s condition and response, often continuing for several years as part of a long-term breast cancer management plan.

Common side effects may include hot flashes, joint pain, fatigue, headache, and nausea. Long-term use may lead to bone thinning (osteoporosis), so calcium and vitamin D supplementation, along with regular bone density checks, is often recommended.

Xtane offers a trusted option for postmenopausal women fighting breast cancer, with proven benefits in survival rates and recurrence prevention.